Arthroplasty Outcomes in Immune Checkpoint Inhibitor-Treated Patients: A Single Center Series

被引:0
|
作者
Elfarra, Yasmine [1 ]
DiCarlo, Edward [2 ]
Vigdorchik, Jonathan [2 ]
Aude, Carlos [3 ]
Ghosh, Nilasha [3 ]
Bass, Anne [3 ]
Chan, Karmela Kim [2 ]
机构
[1] Weill Cornell, New York, NY USA
[2] Hosp Special Surg, New York, NY USA
[3] Weill Cornell Med, Hosp Special Surg, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1919
引用
收藏
页码:3807 / 3809
页数:3
相关论文
共 50 条
  • [31] Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience
    Mooradian, Meghan J.
    Nasrallah, Mazen
    Gainor, Justin F.
    Reynolds, Kerry L.
    Cohen, Justine V.
    Lawrence, Donald P.
    Miloslaysky, Eli M.
    Kohler, Minna J.
    Sullivan, Ryan J.
    Schoenfeld, Sara R.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 1127 - 1132
  • [32] Acute kidney injury in patients treated with immune checkpoint inhibitors: a single-center retrospective study
    Zhou, Ping
    Liu, Bing
    Shen, Ning
    Fan, Xiaoting
    Lu, Shangwei
    Kong, Zhijuan
    Gao, Ying
    Lv, Zhimei
    Wang, Rong
    RENAL FAILURE, 2024, 46 (01)
  • [33] Bone metastases treated with immune checkpoint inhibitors: A single center experience.
    Grover, Punita
    Karivedu, Vidhya
    Zhu, Zheng
    Jandarov, Roman
    Wise-Draper, Trisha Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study
    Abu-Sbeih, Hamzah
    Ali, Faisal S.
    Alsaadi, Dana
    Jennings, Joseph
    Luo, Wenyi
    Gong, Zimu
    Richards, David M.
    Charabaty, Aline
    Wang, Yinghong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [35] Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma
    Jang, Se Ryeong
    Nikita, Nikita
    Banks, Joshua
    Keith, Scott W.
    Johnson, Jennifer M.
    Wilson, Melissa
    Lu-Yao, Grace
    JAMA NETWORK OPEN, 2021, 4 (12)
  • [36] Immune checkpoint inhibitor toxicity and associated outcomes in older patients with cancer
    Hayashi-Tanner, Yacki
    Polewski, Peter J.
    Gaddam, Mamatha
    Fisher, Nancy R.
    Kovacs, Attila J.
    Marinier, David E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (07) : 1011 - 1016
  • [37] Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience
    Bhatlapenumarthi, Vineel
    Patwari, Anannya
    Harb, Antoine J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2789 - 2800
  • [38] Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience
    Vineel Bhatlapenumarthi
    Anannya Patwari
    Antoine J. Harb
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2789 - 2800
  • [39] Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma
    Fletcher, Kylie
    Rehman, Saba
    Irlmeier, Rebecca
    Ye, Fei
    Johnson, Douglas
    ONCOLOGIST, 2024,
  • [40] Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
    Pinato, David J.
    Kaseb, Ahmed
    Wang, Yinghong
    Saeed, Anwaar
    Szafron, David
    Jun, Tomi
    Dharmapuri, Sirish
    Naqash, Abdul Rafeh
    Muzaffar, Mahvish
    Navaid, Musharraf
    Khan, Uqba
    Lee, ChiehJu
    Bulumulle, Anushi
    Yu, Bo
    Paul, Sonal
    Fessas, Petros
    Nimkar, Neil
    Bettinger, Dominik
    Hildebrand, Hannah
    Pressiani, Tiziana
    Abugabal, Yehia, I
    Personeni, Nicola
    Huang, Yi-Hsiang
    Lozano-Kuehne, Jingky
    Rimassa, Lorenza
    Ang, Celina
    Marron, Thomas U.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)